HBW Advisory Services LLC Buys 1,867 Shares of UnitedHealth Group Inc (NYSE:UNH)
HBW Advisory Services LLC lifted its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 22.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,234 shares of the healthcare conglomerate’s stock after acquiring an additional 1,867 shares during the quarter. UnitedHealth Group makes up 1.3% of HBW Advisory Services LLC’s holdings, making the stock its 23rd biggest holding. HBW Advisory Services LLC’s holdings in UnitedHealth Group were worth $3,191,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds also recently modified their holdings of the company. Exchange Traded Concepts LLC raised its position in shares of UnitedHealth Group by 140.0% during the second quarter. Exchange Traded Concepts LLC now owns 132 shares of the healthcare conglomerate’s stock worth $39,000 after acquiring an additional 77 shares during the last quarter. Old North State Trust LLC bought a new position in shares of UnitedHealth Group during the third quarter worth about $39,000. Your Advocates Ltd. LLP raised its position in shares of UnitedHealth Group by 33.3% during the second quarter. Your Advocates Ltd. LLP now owns 400 shares of the healthcare conglomerate’s stock worth $44,000 after acquiring an additional 100 shares during the last quarter. Modus Advisors LLC bought a new position in shares of UnitedHealth Group during the second quarter worth about $62,000. Finally, Engrave Wealth Partners LLC raised its position in shares of UnitedHealth Group by 20.9% during the second quarter. Engrave Wealth Partners LLC now owns 266 shares of the healthcare conglomerate’s stock worth $78,000 after acquiring an additional 46 shares during the last quarter. Institutional investors own 86.39% of the company’s stock.
Shares of NYSE:UNH opened at $329.90 on Friday. The stock has a market cap of $313.52 billion, a price-to-earnings ratio of 18.55, a PEG ratio of 1.44 and a beta of 0.68. The company has a quick ratio of 0.84, a current ratio of 0.84 and a debt-to-equity ratio of 0.60. UnitedHealth Group Inc has a 12-month low of $187.72 and a 12-month high of $333.70. The business’s 50 day moving average is $311.35 and its 200 day moving average is $297.69.
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were given a dividend of $1.25 per share. The ex-dividend date of this dividend was Friday, September 11th. This represents a $5.00 annualized dividend and a dividend yield of 1.52%. UnitedHealth Group’s payout ratio is 33.09%.
In other UnitedHealth Group news, Director Richard T. Burke sold 15,000 shares of the business’s stock in a transaction on Thursday, August 13th. The stock was sold at an average price of $320.59, for a total value of $4,808,850.00. Following the transaction, the director now owns 159,215 shares of the company’s stock, valued at $51,042,736.85. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Marianne D. Short sold 12,000 shares of the business’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $321.34, for a total value of $3,856,080.00. Following the completion of the transaction, the executive vice president now directly owns 140,885 shares in the company, valued at approximately $45,271,985.90. The disclosure for this sale can be found here. In the last three months, insiders sold 47,336 shares of company stock worth $14,928,276. Insiders own 0.80% of the company’s stock.
A number of equities research analysts have weighed in on the company. Mizuho reiterated a “buy” rating and issued a $315.00 target price on shares of UnitedHealth Group in a report on Wednesday, July 15th. ValuEngine upgraded UnitedHealth Group from a “sell” rating to a “hold” rating in a report on Thursday, October 1st. Oppenheimer lifted their target price on UnitedHealth Group from $353.00 to $375.00 and gave the stock an “outperform” rating in a report on Thursday. Credit Suisse Group set a $335.00 target price on UnitedHealth Group and gave the stock a “buy” rating in a report on Wednesday. Finally, Barclays lifted their target price on UnitedHealth Group from $322.00 to $365.00 and gave the stock an “overweight” rating in a report on Tuesday. Four equities research analysts have rated the stock with a hold rating, twenty-one have assigned a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $346.68.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: Day Trading
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.